According to EyePoint Pharmaceuticals 's latest financial reports the company's total assets are HK$2.84 Billion. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2024-12-31 | HK$3.24 B | 17.11% |
2023-12-31 | HK$2.77 B | 96.85% |
2022-12-31 | HK$1.40 B | -31.38% |
2021-12-31 | HK$2.05 B | 188.84% |
2020-12-31 | HK$0.71 B | 25.11% |
2019-12-31 | HK$0.56 B | |
2018-06-30 | HK$0.56 B | 285.78% |
2017-06-30 | HK$0.14 B | -40.57% |
2016-06-30 | HK$0.24 B | -2.2% |
2015-06-30 | HK$0.25 B | 42.79% |
2014-06-30 | HK$0.17 B | 39.42% |
2013-06-30 | HK$0.12 B | -21.13% |
2012-06-30 | HK$0.15 B | -56.42% |
2011-06-30 | HK$0.36 B | 9.44% |
2010-06-30 | HK$0.33 B | 16.51% |
2009-06-30 | HK$0.28 B | -33.89% |
2008-06-30 | HK$0.43 B | -45.71% |
2007-06-30 | HK$0.80 B | -41.01% |
2006-06-30 | HK$1.35 B | 150.53% |
2005-06-30 | HK$0.54 B | 147.83% |
2004-06-30 | HK$0.21 B | 481.92% |
2003-06-30 | HK$37.58 M | |
2001-06-30 | HK$36.81 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
![]() NRC Health
NRC | HK$1.06 B | -62.72% | ๐บ๐ธ USA |
![]() Nymox Pharmaceutical NYMX | HK$2.12 M | -99.93% | Bahamas |